UPDATE 2-Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 [Reuters]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Reuters
Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020 for emergency use ZURICH/GENEVA (Reuters) - Pfizer aims to make 10-20 million doses of a coronavirus vaccine it is developing with Germany’s BioNtech by the end of 2020 for emergency use depending on trial results, the U.S. drugmaker’s vaccines head said on Thursday. The companies, which are developing four vaccine candidates, have already dosed the first humans in Germany and hope to begin a U.S. trial soon, pending approval by regulators. Pfizer, BioNtech and numerous other companies and scientists are in a global race to develop a vaccine for the virus, since there are currently no approved treatments and therapies under study have shown mixed results. Also on Thursday, Britain’s AstraZeneca joined forces with the University of Oxford on a vaccine project that is also already being tested in volunteers. Making millions of doses available within just months, as Pfizer hopes, would mark almost unprecedented speed
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer: The Market Is Still Wrong About It [Seeking Alpha]Seeking Alpha
- FDA chief claims Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]MSNBC.com
- Pfizer Inc. (PFE): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- FDA chief says Biden administration withheld data on heart risk from Covid vaccines [MSNBC.com]MSNBC.com
- Jim Cramer on Pfizer: “I Would Hold on to It” [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- 11/20/25 - Form 424B5
- PFE's page on the SEC website